About Andrew Brunner, MD

Myelodysplastic syndromes are disorders of the bone marrow associated with bone marrow failure and a risk of progression to acute myeloid leukemia. My clinical area of focus and research projects are focused toward understanding treatment patterns and patient outcomes in MDS and other advanced hematologic malignancies, and to develop new treatments for these patients. The therapies available for patients with MDS have not changed in the last decade, and there is critical need to develop new agents and identify the patients most likely to benefit from a given chemotherapy. I am involved in clinical trials for all stages of MDS with an overall goal of tailoring treatment to improve the outcomes of these patients.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Languages:

Locations

Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-726-5130
Phone: 877-726-5130

Medical Education

  • MD, Warren Alpert Medical School of Brown University
  • Residency, Massachusetts General Hospital
  • Fellowship, Brigham and Women's Hospital
  • Fellowship, Dana Farber Cancer Institute

American Board Certifications

  • Internal Medicine, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

My research focuses on the development of clinical trials for the treatment of myelodysplastic syndrome, acute myeloid leukemia, and other cancers of the blood and bone marrow. I also evaluate the translation of novel clinical trial findings into the general population and, using large datasets, attempt to identify those characteristics that may identify ways to tailor therapies to individual patients.

Publications

  • Select Publications:

    • Brunner AM, Li S, Fathi AT, et al. Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission. Br J Haematol. 2016 Jul 19. doi: 10.1111/bjh.14260. [Epub ahead of print]. PMID: 27434660
    • Brunner AM, Hobbs G, Jalbut MM, Neuberg DS, Fathi AT. A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database. Leuk Lymphoma. 2015 Jul 9:1-11. [Epub ahead of print]. PMID: 26155828
    • Brunner AM, Blonquist TM, Sadrzadeh H, et al. Population-Based Disparities in Survival Among Patients with Core-Binding Factor Acute Myeloid Leukemia: A SEER Database Analysis. Leukemia Research. 2014 Jul;38(7):773-80
    • Brunner AM, Kim HT, Coughlin E, et al. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2013 Sep;19(9):1374-80.
    • Brunner AM, Campigotto F, Sadrzadeh H, Drapkin BJ, Chen YB, Neuberg DS, Fathi AT. Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 2013 Jul 15;119(14):2620-9.
    • Brunner AM, Sadrzadeh H, Feng Y, et al. Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia. Am J Hematol. 2013 Aug;88(8):642-6.

Reviews: Comments and Ratings

4.9out of 5(75 Ratings, 34 Comments)

January 2025

He was an excellent provider. I'm so grateful that I came to see him and he gave me such great hope. Thank you and I look forward to seeing him again.


January 2025

Dr, Brunner continues to be an important part of my ongoing care. He listens carefully and respectfully to my questions and concerns. His approach is extremely warm and supportive.


December 2024

Great doctor. Very caring


December 2024

It took a long time for Dr. Brunner to finally get to us, but when he did, he spent a lot of time with me, asked a lot of questions, listened intently, and took the time to attempt to explain some pretty complex subject matter to me and my partner. It was a pretty convoluted diagnosis and next steps, and I felt that he did a great job of trying to ... Read More


December 2024

amazing


November 2024

Dr. Brunner is thoughtful and prepared, explains things many times and is careful about my concerns and questions. I feel very confident with his care.


November 2024

Excellent service. He's a wonderful doctor.


November 2024

Excellent


November 2024

First visit with Dr. Brunner and all went well. I will look forward to having him provide me with my medical care.


October 2024

Dr. Brunner was professional, polished, and personable. His explanation of my symptoms, tests needed, and possible outcomes were easily understood and competently delivered. He left me feeling comfortable that my care was in excellent hands.

View More
Ratings and Comments Powered by NRC Health